Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Chicago
About this trial
The purpose of this study is to determine whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications and help providers improve prescribing decisions for participants. A PTC is a clinical that will test your genes to gather information about your health that may help guide prescribing advice and offer you new information about your prescriptions. Doctors leading this study will look for variations (differences) in your genes that may suggest that you are at greater risk of having side effects or a greater chance of benefiting from certain medications. Individuals in this study will participate for roughly 9 months.
Eligibility criteria
Qualifiers
Adult participants cared for by a participating provider at University of Chicago Medical Center.
Participants must be at least 18 years of age.
Participants prescribed 5 or medication medications and taking a perpetrator drug or a drug with actionable pharmacogenomic information.
Disqualifiers
Participants who have undergone, or are being actively considered for, liver or kidney transplantation.
Participation in another pharmacogenomic study.
Participants who have previously received genotyping from another source.
Inability to understand and give informed consent to participate.
Trial design
Treatments tested in this trial
- Drug-Drug Interaction Profile
- Drug-Gene Interaction Profile
- Standard of Care
Treatment groups
1,300 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov